Simultaneous blocking of the pan‐RAF and S100B pathways as a synergistic therapeutic strategy against malignant melanoma

Melanoma is a very aggressive form of skin cancer. Although BRAF inhibitors have been utilized for melanoma therapy, advanced melanoma patients still face a low five‐year survival rate. Recent studies have shown that CRAF can compensate for BRAF depletion via regulating DNA synthesis to remain melan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ke‐Jia, Ho, Shih‐Hsin, Wu, Chun, Wang, Hui‐Min D., Ma, Dik‐Lung, Leung, Chung‐Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882986/
https://www.ncbi.nlm.nih.gov/pubmed/33377602
http://dx.doi.org/10.1111/jcmm.15994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882986/
https://www.ncbi.nlm.nih.gov/pubmed/33377602
http://dx.doi.org/10.1111/jcmm.15994

Ejemplares similares